Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: A randomized, within-patient controlled trial

British Journal of Dermatology

Volumn 149, Issue 6, 2003, Pages 1259-1265

  McBride, S R ^a,c   Walker, P ^a   Reynolds, N J ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Application frequency; Dithranol; Psoriasis; Randomized controlled trial; Ultraviolet B

Indexed keywords

ANTIINFLAMMATORY AGENT; DITHRANOL;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ADMINISTRATION; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATION; IRRADIATION; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; OUTPATIENT; PATIENT SELECTION; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0347986600     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05653.x     Document Type: Article

References (35)

1. Marsden JR, Coburn PR, Marks J, Shuster S. Measurement of the response of psoriasis to short-term application of dithranol. Br J Dermatol 1983; 109: 209-18.
2. Rogers S, Marks J, Shuster S et al. Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet 1979; i: 455-8.
3. Ingram JT. The approach to psoriasis. Br Med J 1953: ii: 591-4.
4. Schaefer H, Zesch A, Stuttgen G. Penetration, permeation, and absorption of triamcinolone acetonide in normal and psoriatic skin. Arch Dermatol Res 1977; 258: 241-9.
5. Schalla W, Bauer E, Schaefer H. Skin permeability of anthralin. Br J Dermatol 1981; 105: 104-8.
6. Schaefer H, Farber EM, Goldberg LH, Schalla W. Limited application period for dithranol in psoriasis. Br J Dermatol 1980; 102: 571-3.
7. Ryatt KS, Statham BN, Rowell NR. Short-contact modification of the Ingram regime. Br J Dermatol 1984; 111: 455-9.
8. Statham BN, Ryatt KS, Rowell NR. Short-contact dithranol therapy - a comparison with Ingram regime. Br J Dermatol 1984; 110: 703-8.
9. Walker GB, Harrison PV, Seville RH, Smith JF. Short contact dithranol therapy: advantages of a stiff emulsifying ointment base. Br J Dermatol 1989; 120: 277-83.
10. Grattan CEH, Christopher AP, Robinson M. A paired comparison of cream and ointment-based dithranol in short contact treatment of psoriasis. Br J Dermatol 1987; 116: 279-80.
11. Schwarz T, Gschnait F. Anthralin minute entire skin treatment. Arch Dermatol 1985; 121: 1512-15.
12. MacDonald KJS, Marks J. Short contact anthralin in the treatment of psoriasis: a study of different contact times. Br J Dermatol 1986; 114: 235-9.
13. Statham BN, Rowell NR. Short contact dithranol therapy - twice daily and high concentration regimes. Br J Dermatol 1985; 113: 245-6.
14. Jones SK, Campbell WC, MacKie RM. Out-patient treatment of psoriasis: short contact and overnight dithranol therapy compared. Br J Dermatol 1985; 113: 331-7.
15. De Mare S, Calis N, den Hartog G, van de Kerkhof PCM. Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments. Acta Derm Venereol (Stockh) 1989; 69: 449-51.
16. Paramsothy Y, Collins M, Lawrence CM. Effect of UVB therapy and a coal tar bath on short contact dithranol treatment for psoriasis. Br J Dermatol 1988; 118: 783-9.
17. Boer J, Smeenk G. Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. J Am Acad Dermatol 1986; 15: 198-204.
18. Parrish JA, Fitzpatrick TB, Pathak MA. The clinical principles of psoralen photochemotherapy of psoriasis. In: Psoriasis: Proceedings of the Second International Symposium (Farber EM, Cox AJ, eds). New York: Yorke Medical Books, 1977: 272-8.
19. Parrish JA, Stern RS, Pathak MA, Fitzpatrick TB. Photochemotherapy of skin diseases. In: The Science of Photomedicine (Regan JD, Parrish JA, eds). New York: Plenum Press, 1982: 595-623.
20. Cox NH, Farr PM, Diffey BL. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema. Arch Dermatol 1989; 125: 1653-7.
21. Sakuntabhai A, Sharpe GR, Farr PM. Response of psoriasis to twice weekly PUVA. Br J Dermatol 1993; 128: 166-71.
22. Schauder S, Mahrle G. Anthralin inflammation versus UV-erythema in psoriatics. Br J Dermatol 1983; 109: 117-19.
23. Ibbotson SH, Farr PM. Time course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999; 113: 346-50.
24. Behrens-Williams S, Gruss C, Grundmann-Kollmann M et al. Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days. Br J Dermatol 2000; 142: 112-15.
25. Hiller C, Campbell C, Smeaton I. How stable is dithranol? Pharmacy in Practice 1995; 5: 428-31.
26. Diffey BL. The spectral emissions from ultraviolet radiation lamps used in dermatology. Photodermatology 1986; 3: 179-85.
27. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
28. Squire B. Treatment of psoriasis by an ointment of chrysophanic acid. Br Med J 1876; 2: 819-20.
29. Schaefer H. Short-contact therapy. Arch Dermatol 1985; 121: 1505-8.
30. Brun P, Juhlin L, Schalla W. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses. Acta Derm Venereol (Stockh) 1984; 64: 174-7.
31. Runne U, Kunze J. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 1982; 106: 135-9.
32. Lebwohl M, Berman B, France DS. Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy. J Am Acad Dermatol 1985; 13: 780-4.
33. Marley WM, Hernandez AD, Josephs JA, Dawkins L. The effectiveness of low-strength anthralin in psoriasis. Arch Dermatol 1982; 118: 906-8.
34. Goodfield MJ, Hull SM, Cunliffe WJ. The systemic effect of dithranol treatment in psoriasis. Acta Derm Venereol (Stockh) 1994; 74: 295-7.
35. Dawe RS, Cameron H, Yule S et al. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138: 1071-6.